ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AZN Astrazeneca Plc

11,916.00
564.00 (4.97%)
Last Updated: 10:34:02
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  564.00 4.97% 11,916.00 11,914.00 11,918.00 12,086.00 11,850.00 11,890.00 906,729 10:34:02
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.06 184.94B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 11,352p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,348.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £184.94 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.06.

Astrazeneca Share Discussion Threads

Showing 2701 to 2721 of 6150 messages
Chat Pages: Latest  114  113  112  111  110  109  108  107  106  105  104  103  Older
DateSubjectAuthorDiscuss
01/6/2020
09:46
quite a pullback and trading well below AZN in USA which is lead market . I think futures opens at about 11.30am UK time
arja
01/6/2020
09:46
quite a pullback and trading well below AZN in USA which is lead market . I think futures opens at about 11.30am UK time
arja
30/5/2020
09:25
hxxps://www.fiercepharma.com/pharma/asco-stomach-cancer-astrazeneca-and-daiichi-s-enhertu-goes-where-roche-s-kadcyla-couldn-t
beckers2008
29/5/2020
12:23
Precisely!
bountyhunter
29/5/2020
11:52
Damn expensive stock but you have to pay for quality. Can see 10000p soon
spoonfed1
29/5/2020
09:29
...topped up again here this morning, what's not to like about AZN!?
bountyhunter
29/5/2020
07:31
Heading for above 100 over a period .
holts
29/5/2020
07:08
Yes very significant news, as can be seen by the 6% after hours rise in the US.
bountyhunter
29/5/2020
07:06
Excellent news, can see this doing very well today. Onwards and upwards.
gateside
28/5/2020
23:38
Up 6% in US post market on tagrisso data
smcni1968
27/5/2020
21:43
Sector rotation but US quote,while down,closed around £85-70
steeplejack
27/5/2020
14:13
Just prospect of lockdown easing - there is no quantification to it, just short covering and momentum.

Taking the funds from other sectors, rotation, from stuff like this and commodities. Always happens and always will happen - it's what makes a living for the brokers, innit?

imastu pidgitaswell
27/5/2020
13:26
How come the airlines and some others are rocking ?
abdullla
27/5/2020
11:23
Thing is looks like vaccine won't be ready if at all for months. Vaccine normally takes 10 years they are trying to do it in 6 months, but optimistic.
montyhedge
27/5/2020
07:06
Good article
mac15
26/5/2020
23:24
Cheers and yes it was amaretto1 , thanks steeplejack


buywell has been looking at what might be coming down the road over the next 6 to 9 months. IMO it gives rise to some concern re lockdowns being relaxed .

Covid-19 case numbers are still running at circa 100K a day worldwide after hitting the worst ever number of 106k since the outbreak started less than a week ago.

Clearly Covid-19 Wave 1 is not yet over

USA daily case numbers are running at circa 20K a day , it is not yet over there also.

Latin America and India are now in crisis , Russia is around 9K cases a day and 6M cases by the end of this week looks a given. A Covid-19 kill rate of 6.66% will then equate to 400k deaths.

buywell is now of the opinion that this Wave 1 will most likely hit 10M cases by mid July .

Hopefully hot weather will then ease numbers downwards till the fall when it gets colder.

buywell expects numbers to begin to rise once more by the end of September in the absence of no vaccine peaking around Xmas/mid Jan 2021.

Now here comes the nasty bit

Just how high case numbers rise in Wave 2 will depend upon when or indeed lockdown Mk2 gets implemented by politicians. Some will some won't but buywell feels that the economic damage will be so great by say end of October/start November crunch time will have arrived.

Assuming that most by then in the absence of a vaccine will opt for the 'herd immunity' goal , which was attained in 3 waves in the last pandemic 1918/1919 in around 15 months , the politicos will roll the dice and Wave 2 will be a bad one as it was with Spanish Flu , 6 X the size of Wave 1.

Will Hospitals and Health Services cope ?

They just did in the UK , USA and EU . But whether they do next time depends upon Health Ministers and Governments preparing them over the next few months both with extra staff, extra ICU beds , extra ventilators and equipment that Wave 1 has indicated works best , and adequate PPE in quality and quantity.

The potential size of Wave 2 could be 60M people and 4 Million deaths

In the absence of a vaccine another Wave 3 could follow as per the Spanish Flu model , that thankfully should be the last as 'herd immunity' gets attained.

As long as SARS-COV-2 has not mutated into something worse in terms of its kill rate.

A vaccine has never been successfully made to date for any Coronavirus , the odds are therefore not good that one will be made this time. Plus the fact that there have been 3 distinct mutated strains in evidence in China , the EU and the USA , plus another 27 mutated strains to date also brings into prospect that current vaccines now in production ( yes they are assuming testing on humans is ok) works on the mutated strains killing humans in March 2021.

This is also why buywell believes the dice will be rolled for no more lockdowns by most countries ie the no vaccine scenario.

It is a UK fact that 'herd immunity' is the goal
Boris Johnson's Talk of 'Herd Immunity' Raises Alarms
www.courthousenews.com › boris-johnsons-talk-of-her...
Boris Johnson's Talk of 'Herd Immunity' Raises Alarms.

A last thought re those countries that do NOT want to do more Lockdowns.

These might include places like Australia, New Zealand , Taiwan and other island nations like those in the Pacific.

Whilst 'Herd Immunity' would have been attained by the greater part of the world at the cost of circa 100M cases in 3 Waves together with circa 6.66 Million deaths.

NO Herd Immunity will exist in those countries that locked down hard again.

Hence they will be sitting ducks when airplanes carrying the odd asymptomatic case of Covid-19 ( Covid carrier shows no symptoms) in the event of no vaccine roll out .



Plan and Prepare for the worst outcome/s is what Politicos should now be doing IMO


boris - Laura Doomsburg is out to get you

You need to get out a statement laying out your plans to rebuild the NHS to be fit for purpose in a world of Coronavirus Pandemics , SARS-COV-3 is coming.

All IMHO , dyor

buywell3
26/5/2020
19:10
It was 3.7 million
amaretto1
26/5/2020
16:07
Very interesting stuff buywell3.
steeplejack
22/5/2020
11:26
Bloomberg - some much bigger trials:

"The University of Oxford and AstraZeneca Plc have begun recruiting more than 10,000 subjects for advanced human studies of one of the world’s fastest-moving experimental Covid-19 vaccines.

A smaller part of the trial will expand the age range of testing to children from 5 to 12 years old and adults 56 and older, according to a statement. The other, larger stage will test the vaccine’s effectiveness in volunteers 18 and older.

Companies around the world are racing to develop weapons to fight the pandemic that has cloistered large populations and battered economies. AstraZeneca received a boost in its efforts to get the immunization tested and ready for use when the U.S. pledged as much as $1.2 billion toward development on Thursday.

Adult subjects in the studies will be randomly chosen to receive one or two doses of the Oxford candidate or an already licensed vaccine against meningococcus for comparison.

The volunteers will be recruited across the U.K. and will record their reactions in an e-diary and attend some follow-up visits. Some will be given swabs for taking samples at home.

The proposed Covid-19 vaccine is made from a weakened version of a common cold virus that’s genetically changed to make it unable to grow in humans. More than 1,000 people have already received it in an early-stage trial that began in April."

alphorn
22/5/2020
11:03
But a bit surprising that AZN has fallen sharply after it spiked yesterday on
the covid-19 news . If DOw and US markets recover , might be worth buying now for a day trade !

arja
22/5/2020
10:49
Astra far superior growth in shareprice to GSK.GSK shareprice below what it was 25 years ago, ok 4.5% yield, but what a disappointing investment.
montyhedge
Chat Pages: Latest  114  113  112  111  110  109  108  107  106  105  104  103  Older

Your Recent History

Delayed Upgrade Clock